Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aspirin wars: the optimal dose of aspirin prevent stroke.

× No keyword cloud information.

9 in total

1. Development of a decision aid for atrial fibrillation who are considering antithrombotic therapy.

Authors: M Man-Son-Hing; A Laupacis; A M O'Connor; R G Hart; G Feldman; J L Blackshear; D C Anderson
Journal: J Gen Intern Med Date: 2000-10 Impact factor: 5.128

2. Cost-effectiveness analysis of antiplatelet therapy in the prevention of recurrent stroke in the UK. Aspirin, dipyridamole and aspirin-dipyridamole.

Authors: M Chambers; J Hutton; J Gladman
Journal: Pharmacoeconomics Date: 1999-11 Impact factor: 4.981

3. Application of the findings of the European Stroke Prevention Study 2 (ESPS-2) to a New Zealand ischaemic stroke cost analysis.

Authors: G Scott; H M Scott
Journal: Pharmacoeconomics Date: 1997-12 Impact factor: 4.981

4. Salicylic acid binds NPR3 and NPR4 to regulate NPR1-dependent defense responses.

Authors: Magali Moreau; Miaoying Tian; Daniel F Klessig
Journal: Cell Res Date: 2012-06-26 Impact factor: 25.617

Review 5. Place of drug therapy in the treatment of carotid stenosis.

Authors: Norberto Andaluz; Mario Zuccarello
Journal: CNS Drugs Date: 2005 Impact factor: 5.749

6. Is acetylsalicylic acid plus dipyridamole superior to ASA alone for secondary prevention of stroke?

Authors: B Dalton; C Papoushek; M F Evans
Journal: Can Fam Physician Date: 2001-11 Impact factor: 3.275

Review 7. Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.

Authors: Eugene D Kaplan; Ralph L Sacco
Journal: Curr Neurol Neurosci Rep Date: 2002-01 Impact factor: 5.081

8. Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.

Authors: B S Hellemons; M Langenberg; J Lodder; F Vermeer; H J Schouten; T Lemmens; J W van Ree; J A Knottnerus
Journal: BMJ Date: 1999-10-09

9. Acetylsalicylic acid as an adjuvant therapy for schizophrenia.

Authors: Wijnand Laan; Jean-Paul Selten; René S Kahn; Anne-Margriet Huisman; Cobi J Heijnen; Diederick E Grobbee; Huibert Burger
Journal: Trials Date: 2006-10-23 Impact factor: 2.279

9 in total